Avricore Health (AVCRF) Net Cash Flow Growth (1y) (2015 - 2025)
Avricore Health (AVCRF) Net Cash Flow Growth (1y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -298.36% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -7,202.13% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 665.15% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 117.44% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 722.22% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -58.16% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -320.00% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -1,722.22% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -273.33% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -218.03% |
| Jun 30, 2025 | -197.79% |
| Mar 31, 2025 | -58.14% |
| Sep 30, 2024 | 697.89% |
| Jun 30, 2024 | 778.58% |
| Mar 31, 2024 | 386.23% |
| Dec 31, 2023 | 54.70% |
| Sep 30, 2023 | 85.99% |
| Jun 30, 2023 | 90.33% |
| Mar 31, 2023 | 41.35% |
| Dec 31, 2022 | -9.17% |
| Sep 30, 2022 | -740.12% |
| Jun 30, 2022 | -33.49% |
| Mar 31, 2022 | -107.56% |
| Dec 31, 2021 | -182.66% |
| Sep 30, 2021 | 61.46% |
| Jun 30, 2021 | -47.46% |
| Mar 31, 2021 | 467.03% |
| Dec 31, 2020 | 775.29% |
| Sep 30, 2020 | -1,224.74% |